NEWTON, MA and NEW YORK, NY (SEPTEMBER 19, 2017) – Tikun Olam, a pioneer in cannabis research, and MariMed Inc. (OTCQB:MRMD), a preeminent management company in the U.S. medical cannabis industry, announced an expansion of their licensing agreement for Tikun Olam products to be grown, manufactured and sold through MariMed’s network of managed and affiliated licensed facilities throughout the United States, according to a press release.
This new agreement brings Tikun Olam’s premium cannabis products, years of proprietary, peer-reviewed scientific research and unprecedented clinical data collection to four additional MMJ-legal U.S. states, its most expansive agreement to date. Tikun Olam and MariMed’s relationship began in 2015 with a pilot program in Delaware and marked the first time that U.S. patients had access to the world’s only cannabis strains proven to deliver symptomatic relief for specific conditions including cancer, PTSD, epilepsy, Crohn’s Disease/Colitis, chronic pain and neuropathy, to name a few.
“After the great success of our program in Delaware, MariMed is excited to bring Tikun to our expanding national network of legal cannabis production and dispensary facilities,” said Robert Fireman, CEO of MariMed Inc. “Tikun Olam's empirical data on clinical effectiveness is unsurpassed, and we look forward to educating healthcare professionals and offering Tikun's products to tens of thousands of new patients nationwide.”
MariMed will introduce Tikun’s exclusive strains and products in state-of-the-art, regulatory compliant and fully operational cultivation and medical marijuana dispensaries in Rhode Island, Maryland, Massachusetts and Illinois in 2018. Tikun products will be available in flower, vape cartridges, topicals, tinctures and edibles utilizing at least six Tikun branded strains, including its world-renowned Avidekel high-CBD strain. In addition to Delaware, Tikun products have launched in Nevada (March 2017) and are expected to launch Washington (November 2017).
“Tikun Olam is delighted to expand our relationship with MariMed,” said Tikun CEO Bernard Sucher. “MariMed utilizes the 'best practices' and standards for cultivation and production and their qualified distribution channels allow us to bring our proven wellness products to more U.S. patients than ever before.”
